| Medical and Health Sciences | Lifetime | 379 | CA 19 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 547 | CA 18 | 99.88 |
| Cardiology and Cardiovascular Medicine | Lifetime | 72 | CA 7 | 99.94 |
| Internal Medicine | Lifetime | 7 | CA 4 | 99.75 |
| Rheumatology | Lifetime | 652 | CA 30 | 96.78 |
| Hematology | Lifetime | 715 | CA 30 | 93.76 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 86 | CA 4 | 99.64 |
| Internal Medicine | 2021-2025 | 27 | CA 7 | 96.96 |
| Medical Genetics | 2021-2025 | 279 | CA 8 | 83.92 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 4 | CA 1 | 99.95 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 7 | CA 3 | 99.96 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 14 | CA 2 | 99.92 |
| Cardiac Arrhythmias and Treatments | Lifetime | 112 | CA 9 | 99.59 |
| Acute Myocardial Infarction Research | Lifetime | 98 | CA 4 | 99.67 |
| Folate and B Vitamins Research | Lifetime | 78 | CA 3 | 98.77 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 29 | CA 7 | 99.01 |
| Acute Ischemic Stroke Management | Lifetime | 294 | CA 16 | 99.09 |
| Inflammatory mediators and NSAID effects | Lifetime | 176 | CA 6 | 98.69 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 179 | CA 18 | 98.52 |
| Lipoproteins and Cardiovascular Health | Lifetime | 379 | CA 28 | 98.38 |
| GDF15 and Related Biomarkers | Lifetime | 64 | CA 4 | 95.33 |
| Inflammasome and immune disorders | Lifetime | 344 | CA 11 | 96.66 |
| Peripheral Artery Disease Management | Lifetime | 622 | CA 13 | 96.69 |
| Neurological Complications and Syndromes | Lifetime | 245 | CA 9 | 95.75 |
| Blood transfusion and management | Lifetime | 425 | CA 48 | 94.56 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 975 | CA 31 | 94.56 |
| Vitamin K Research Studies | Lifetime | 316 | CA 14 | 91.73 |
| Blood donation and transfusion practices | Lifetime | 660 | CA 44 | 88.23 |
| Intramuscular injections and effects | Lifetime | 652 | CA 65 | 68.92 |
| Case Reports on Hematomas | Lifetime | 953 | CA 37 | 66.54 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 16 | CA 2 | 99.71 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 12 | CA 1 | 99.47 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 28 | CA 4 | 99.44 |
| Cardiac Arrhythmias and Treatments | 2021-2025 | 456 | CA 25 | 96.41 |
| Peripheral Artery Disease Management | 2021-2025 | 210 | CA 10 | 94.27 |
| Inflammasome and immune disorders | 2021-2025 | 218 | CA 3 | 92.53 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 113 | CA 5 | 94.16 |
| Acute Myocardial Infarction Research | 2021-2025 | 479 | CA 13 | 94.44 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 212 | CA 14 | 87.85 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 460 | CA 19 | 84.74 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 944 | CA 31 | 85.52 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 447 | CA 11 | 70.86 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 623 | CA 16 | 56.56 |
| Vitamin K Research Studies | 2021-2025 | 337 | CA 11 | 53.10 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 808 | CA 5 | 39.45 |